Business

5 Next-Generation Psychedelics Entering Clinical Trials This YearShutterstock

5 Next-Generation Psychedelics Entering Clinical Trials This Year

,
Modernized psychedelic medicine is coming, whether you like it or not, so here are five of the most exciting next-generation psychedelics on the horizon.

Psychedelic Business Spotlight – May 27

,
This week in psychedelic business news: New patents; another Health Canada SAP Approval; and legal psilocybin rules for Oregon.
CATALYST Summit: 3 Psychedelic Speakers to Catch This Weekend

CATALYST Summit: 3 Psychedelic Speakers to Catch This Weekend

,
Even if you can't be there in person, it's not too late to get a discounted pass to tune in online. 
Psychedelic Business Spotlight - May 20

Psychedelic Business Spotlight – May 20

,
This week in psychedelic business news: Another psychedelic merger; an Optimi Health acquisition; and good news for alcohol abuse treatment.

Psychedelic Capitalism Takes a Trip to Davos

,
From May 21-26, for the first time, the Davos Forum will feature The House of Psychedelics. Here's why that matters for the psychedelics industry.
MindMed, atai Life Sciences, Compass Pathways: A Psychedelic Stock AnalysisShutterstock

Comparing MindMed, Atai Life Sciences, Compass Pathways: A Psychedelic Stock Analysis

, ,
Our resident psychedelic investor explains a handful of important metrics to study when analyzing and comparing psychedelic stocks.

MindMed Releases LSD for Anxiety Data ! (MNMD, MMED)

Get your 20%-off tickets to the Catalyst Psychedelics Summit in Kingston Ontario, May 20th-23rd: www.eventbrite.ca/e/153409882087/?discount=SPOTLIGHT20 Join our Newsletter (scroll to the bottom of the page and sign up):...

Psychedelic Business Spotlight – May 13

,
This week in psychedelic business news: Beckley Retreats set launch; another shark swims into the psychedelics industry; and MindMed shares promising LSD study results.
MindMed's Phase 2 LSD Trial Treating Anxiety Was a SuccessShutterstock

MindMed’s Phase 2 LSD Trial Treating Anxiety Was a Success

, ,
Researchers at PSYCH Symposium reveal promising results from double-blind, placebo-controlled study with 46 patients.

© 2022 Psychedelic Spotlight. | Owned and operated by PSYC Media Corporation, Inc. a US publicly traded company (OTCPink: PSYC) | All Rights Reserved.